targeted capture massively parallel sequencing human exomes
genome-wide association studies suggest common genetic variants explain modest fraction heritable risk common diseases raising question whether rare variants account significant fraction unexplained heritability although dna sequencing costs fallen markedly remain far necessary rare novel variants routinely identified genome-wide scale large cohorts therefore sought develop second-generation methods targeted sequencing protein-coding regions exomes reduce costs enriching discovery highly penetrant variants report targeted capture massively parallel sequencing exomes humans include eight hapmap individuals representing three populations four unrelated individuals rare dominantly inherited disorder freeman-sheldon syndrome fss demonstrate sensitive specific identification rare common variants megabases coding sequence using fss proof-of-concept show candidate genes mendelian disorders can identified exome sequencing small number unrelated affected individuals strategy may extendable diseases complex genetics larger sample sizes appropriate weighting non-synonymous variants predicted functional impact
